05 January 2023
Result of General Meeting & Open Offer
Shield Therapeutics plc announces that it has conditionally raised total gross proceeds of approximately £2.6 million through the Open Offer which was announced on 13 December 2022
The Company additionally announces that at the General Meeting held earlier today, all Resolutions to approve, inter alia, the proposed Placing, Subscription and Open Offer were duly passed by shareholders. The Board reports that resolutions 1 and 3 passed as ordinary resolutions and resolutions 2 and 4 were passed as special resolutions.
For full details click here